Vytrus Biotech Statistics
Total Valuation
Vytrus Biotech has a market cap or net worth of EUR 36.87 million. The enterprise value is 36.11 million.
Market Cap | 36.87M |
Enterprise Value | 36.11M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Vytrus Biotech has 7.52 million shares outstanding. The number of shares has increased by 11.71% in one year.
Current Share Class | 7.52M |
Shares Outstanding | 7.52M |
Shares Change (YoY) | +11.71% |
Shares Change (QoQ) | -0.44% |
Owned by Insiders (%) | 34.62% |
Owned by Institutions (%) | 15.28% |
Float | 3.70M |
Valuation Ratios
The trailing PE ratio is 36.11 and the forward PE ratio is 19.78.
PE Ratio | 36.11 |
Forward PE | 19.78 |
PS Ratio | 6.05 |
PB Ratio | 5.06 |
P/TBV Ratio | 11.46 |
P/FCF Ratio | 21.15 |
P/OCF Ratio | 20.00 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.68, with an EV/FCF ratio of 20.72.
EV / Earnings | 35.37 |
EV / Sales | 5.93 |
EV / EBITDA | 30.68 |
EV / EBIT | 36.66 |
EV / FCF | 20.72 |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.24.
Current Ratio | 3.03 |
Quick Ratio | 2.60 |
Debt / Equity | 0.24 |
Debt / EBITDA | 1.51 |
Debt / FCF | 1.02 |
Interest Coverage | 8.00 |
Financial Efficiency
Return on equity (ROE) is 16.23% and return on invested capital (ROIC) is 7.49%.
Return on Equity (ROE) | 16.23% |
Return on Assets (ROA) | 6.02% |
Return on Invested Capital (ROIC) | 7.49% |
Return on Capital Employed (ROCE) | 9.97% |
Revenue Per Employee | 164,605 |
Profits Per Employee | 27,595 |
Employee Count | 37 |
Asset Turnover | 0.60 |
Inventory Turnover | 1.07 |
Taxes
Income Tax | -119,270 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.52% in the last 52 weeks. The beta is 0.15, so Vytrus Biotech's price volatility has been lower than the market average.
Beta (5Y) | 0.15 |
52-Week Price Change | +55.52% |
50-Day Moving Average | 3.90 |
200-Day Moving Average | 2.83 |
Relative Strength Index (RSI) | 75.25 |
Average Volume (20 Days) | 4,887 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vytrus Biotech had revenue of EUR 6.09 million and earned 1.02 million in profits. Earnings per share was 0.14.
Revenue | 6.09M |
Gross Profit | 5.50M |
Operating Income | 984,986 |
Pretax Income | 901,738 |
Net Income | 1.02M |
EBITDA | 1.18M |
EBIT | 984,986 |
Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 2.53 million in cash and 1.77 million in debt, giving a net cash position of 756,325 or 0.10 per share.
Cash & Cash Equivalents | 2.53M |
Total Debt | 1.77M |
Net Cash | 756,325 |
Net Cash Per Share | 0.10 |
Equity (Book Value) | 7.29M |
Book Value Per Share | 0.97 |
Working Capital | 2.54M |
Cash Flow
In the last 12 months, operating cash flow was 1.84 million and capital expenditures -100,999, giving a free cash flow of 1.74 million.
Operating Cash Flow | 1.84M |
Capital Expenditures | -100,999 |
Free Cash Flow | 1.74M |
FCF Per Share | 0.23 |
Margins
Gross margin is 90.28%, with operating and profit margins of 16.17% and 16.76%.
Gross Margin | 90.28% |
Operating Margin | 16.17% |
Pretax Margin | 14.81% |
Profit Margin | 16.76% |
EBITDA Margin | 19.33% |
EBIT Margin | 16.17% |
FCF Margin | 28.62% |
Dividends & Yields
Vytrus Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.71% |
Shareholder Yield | n/a |
Earnings Yield | 2.77% |
FCF Yield | 4.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Vytrus Biotech has an Altman Z-Score of 3.76 and a Piotroski F-Score of 7.
Altman Z-Score | 3.76 |
Piotroski F-Score | 7 |